Stockreport

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company [Yahoo! Finance]

Merrimack Pharmaceuticals, Inc.  (MACK) 
Last merrimack pharmaceuticals, inc. earnings: 3/6 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.merrimack.com/investor-relations
PDF A total of 7 investors have a majority stake in the company with 51% ownership Using data from company's past performance alongside ownership research, one can better [Read more]